1,3-Butadiene: III. Assessing carcinogenic modes of action

References

• Albertini RJ, Sram RJ, Vacek PM, Lynch J, Wright M, Nicklas JA, Boogaard PJ, Henderson RF, Swenberg JA, Tates AD, Ward JB Jr. (2001). Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact 135–136:429–453.
   PubMed Web of Science ®Google Scholar
• Albertini RJ, Sram RJ, Vacek PM, Lynch J, Nicklas JA, van Sittert NJ, Boogaard PJ, Henderson RF, Swenberg JA, Tates AD, Ward JB Jr, Wright M, Ammenheuser MM, Binkova B, Blackwell W, de Zwart F.A, Krako D, Krone J, Megens H, Musilova P, Rajska G, Ranasinghe A, Rosenblatt JI, Rossner P, Rubes J, Sullivan L, Upton P, Zwinderman AH. (2003a). Biomarkers in Czech workers exposed to 1,3-butadiene: A transitional epidemiologic study. Res Rep Health Effects Inst (116):1–141.
   Google Scholar
• Albertini R, Clewell H, Himmelstein MW, Morinello E, Olin S, Preston J, Scarano L, Smith MT, Swenberg J, Tice R, Travis C. (2003b). The use of non-tumor data in cancer risk assessment: Reflections on butadiene, vinyl chloride, and benzene. Regul Toxicol Pharmacol 37:105–132.
   PubMed Web of Science ®Google Scholar
• Albertini RJ, Sram RJ, Vacek PM, Lynch J, Nicklas JA, McDonald J, Swenberg JA. (2007). Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: Female-male comparisons. Chem Biol Interact 166:63–77.
   PubMed Web of Science ®Google Scholar
• Albertini RA, Carson ML, Kirman CR, Gargas ML. (2010). 1,3-Butadiene: II. Review of mutagenicity of its relevance for cancer potency. Crit Rev Toxicol 40(Suppl 1): this issue.
   Google Scholar
• Barnes DJ, Melo JV. (2002). Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia. Acta Haematol 108:180–202.
   PubMed Web of Science ®Google Scholar
• Bastlova T, Vodicka P, Peterkova K, Hemminki K, Lambert B. (1995). Styrene oxide-induced HPRT mutations DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis 16:2357–2362.
   PubMed Web of Science ®Google Scholar
• Biernaux C, Loos M, Sels A, Huez G, Stryckmans P. (1995). Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118–3122.
   PubMed Web of Science ®Google Scholar
• Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A, Pushailerova D, Znaor A, Kelecsenyi Z, Kuritnaitis J, Rachtan J, Forni A, Vermeulen R, Bonassi S. (2007). Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe. Am J Epidemiol 165:36–43.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P. (1995). Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133–135.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Hagmar L, Stromberg U, Montagud A.H, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen I.L, Knudson L.E, Norppa H. (2000). Chromosome aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 60:1619–1625.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–792.
   PubMed Web of Science ®Google Scholar
• Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. (1998). The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease. Blood 92:3362–3367.
   PubMed Web of Science ®Google Scholar
• Boysen G, Georgieva NI, Upton PB, Jayaraj K, Li Y, Walker VE, Swenberg JA. (2004). Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Cancer Res 64:8517–8520.
   PubMed Web of Science ®Google Scholar
• Bucher JR, Melnick RL, Hildebrandt PK. (1993). Lack of carcinogenicity in mice exposed once to high concentrations of 1,3-butadiene. J Natl Cancer Inst 85:1866–1867.
   PubMedGoogle Scholar
• Cereser C, Boget S, Parvaz P, Revol A. (2001). Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death. Toxicology 163:153–162.
   PubMed Web of Science ®Google Scholar
• Checkoway H, Williams TM. (1982). A hematology survey of workers at a styrene-butadiene synthetic rubber manufacturing plant. Am Ind Hyg Assoc J 43:164–169.
   PubMed Web of Science ®Google Scholar
• Chen Z, Sandberg AA. (2002). Molecular cytogenetic aspects of hematological malignancies: Clinical implications. Am J Med Genet 115:130–141.
   PubMed Web of Science ®Google Scholar
• Cheng H, Sathiakumar N, Graff J, Matthews R, Delzell E. (2007). 1,3-Butadiene and leukemia among synthetic rubber industry workers: Exposure-response relationships. Chem Biol Interact 166:15–24.
   PubMed Web of Science ®Google Scholar
• de Meester C. (1988). Genotoxic properties of 1,3-butadiene. Mutat Res 195:273–281.
   PubMed Web of Science ®Google Scholar
• Delzell E, Sathiakumar N, Hovinga M, Macaluso M, Julian J, Larson R, Cole P, Muir DC. (1996). A follow-up study of synthetic rubber workers. Toxicology 113:182–189.
   PubMed Web of Science ®Google Scholar
• Delzell E, Macaluso M, Sathiakumar N, Matthews R. (2001). Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry. Chem Biol Interact 135–136:515–534.
   PubMed Web of Science ®Google Scholar
• Delzell E, Sathiakumar N, Graff J, Macaluso M, Maldanado G, Matthews R. (2006). An updated study of mortality among North American synthetic rubber industry workers. Res Rep Health Effects Inst (132):1–63.
   Google Scholar
• Divine BJ, Hartman CM. (2001). A cohort mortality study among workers at a 1,3-butadiene facility. Chem Biol Interact 135–136:535–553.
   PubMed Web of Science ®Google Scholar
• Doerr JK, Hooser SB, Smith BJ, Sipes IG. (1995). Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: Role of diepoxides. Chem Res Toxicol 8:963–969.
   PubMed Web of Science ®Google Scholar
• Doerr JK, Hollis EA, Sipes IG. (1996). Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Toxicology 113:128–136.
   PubMed Web of Science ®Google Scholar
• Druker BJ, Tamura S, Buchdunger E, Ohno S Segal GM, Fanning S, Zimmerman J, Lyndon NB. (1996). Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561–566.
   PubMed Web of Science ®Google Scholar
• Druker BJ, Sawyers CL, Kantarijan H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. (2001). Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038–1042.
   PubMed Web of Science ®Google Scholar
• Elovaara E, Engstrom K, Nakajima T, Park SS, Gelboin HV, Vainio H. (1991). Metabolism of inhaled styrene in acetone-, phenobarbital- and 3-methylcholanthrene-pretreated rats: Stimulation and stereochemical effects by induction of cytochromes P450IIE1, P450IIB and P450IA. Xenobiotica 21:651–661.
   PubMed Web of Science ®Google Scholar
• Elskens MT, Penninckx MJ. (1997). Thiram and dimethyldithiocarbamic acid interconversion in Saccharomyces cerevisiae: A possible metabolic pathway under the control of the glutathione redox cycle. Appl Environ Microbiol 63:2857–2862.
   PubMed Web of Science ®Google Scholar
• Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Baur C, Csanady GA. (1993). A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: Predictions for human exposure. IARC Sci Publ 127:65–78.
   Google Scholar
• Finette BA. (2006). Analysis of mutagenic V(D)J recombinase medidated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children. DNA Repair (Amst) 5:1049–1064.
   PubMed Web of Science ®Google Scholar
• Fred C, Tornqvist M, Granath F. (2008). Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model. Cancer Res 68:8014–8021.
   PubMed Web of Science ®Google Scholar
• Georgieva NI, Boysen G, Bordeerat N, Walker VE, Swenberg JA. (2010) Exposure-response of 1,2,3,4-diepoxybutane specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene. Toxicol Sci xx:xx–xx.
   Google Scholar
• Gilliland DG, Griffin J.D. (2002). The roles of FLT3 in hematopoiesis and leukemia. Blood 100:1532–1542.
   PubMed Web of Science ®Google Scholar
• Goggin M, Swenberg JA, Walker VE, Tretyakova N. (2009). Molecular dosimetry of 1,2,3,4-diepoxybutane-induced DNA-DNA cross-links in B6C3F1 mice and F344 rats exposed to 1,3-butadiene by inhalation. Cancer Res 69:2479–2486.
   PubMed Web of Science ®Google Scholar
• Goodrow T, Reynolds S, Maronpot R, Anderson M. (1990). Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Cancer Res 50:4818–4823.
   PubMed Web of Science ®Google Scholar
• Goodrow TL, Nichols WW, Storer RD, Anderson MW, Maronpot RR. (1994). Activation of H-ras is prevalent in 1,3-butadiene-induced and spontaneously occurring murine Harderian gland tumors. Carcinogenesis 15:2665–2667.
   PubMed Web of Science ®Google Scholar
• Graff JJ, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. (2005). Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J Occup Environ Med 47:916–932.
   PubMed Web of Science ®Google Scholar
• Greaves MF. (2004). Biological models for leukaemia and lymphoma. IARC Sci Publ 157:351–372.
   Google Scholar
• Green T, Toghill A, Moore R. (2001). The influence of co-exposure to dimethyldithiocarbamate on butadiene metabolism. Chem Biol Interact 135–136:585–598.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Cozen W. (2007) Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prevent 16:405–409
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Kim DH, Iwasaki M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–179.
   PubMed Web of Science ®Google Scholar
• Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I. (1994). Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919–2922.
   PubMed Web of Science ®Google Scholar
• Hagmar L, Stromberg U, Bonassi S, Hansteen IL, Knudson L, Lindholm C, Norppa H. (2004). Impact of types of lymphocyte chromosomal aberrations on human cancer risk: Results from Nordic and Italian cohorts. Cancer Res 64:2258–2263.
   PubMed Web of Science ®Google Scholar
• Hasegawa R, Takahashi M, Furukawa F, Toyoda K, Sato H, Jang JJ, Hayashi Y. (1998). Carcinogenicity study of tetramethylthiuram disulfide (thiram) in F344 rats. Toxicology 51:155–165.
   Google Scholar
• Hayes RB, Xi L, Bechtold WE, Rothman N, Yao M, Henderson R, Zhang L, Smith MT, Zhang D, Wiemels J, Dosemeci M, Yin S, O’Neill JP. (1996). hprt mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology 113:100–105.
   PubMed Web of Science ®Google Scholar
• Hayes RB, Zhang L, Yin S, Swenberg JA, Xi L, Wiencke J, Bechtold WE, Yao M, Rothman N, Haas R, O’Neill JP, Zhang D, Wiemels J, Dosemeci M, Li G, Smith MT. (2000). Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21:55–62.
   PubMed Web of Science ®Google Scholar
• Hayes RB, Zhang L, Swenberg JA, Yin SN, Xi L, Wiencke J, Bechtold WE, Yao M, Rothman N, Haas R, O’Neill JP, Wiemels J, Dosemeci M, Li G, Smith MT. (2001). Markers for carcinogenicity among butadiene-polymer workers in China. Chem Biol Interact 135–136:455–464.
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. (1997). Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol 27:1–108.
   PubMed Web of Science ®Google Scholar
• Hong HH, Devereux TR, Melnick RL, Moomaw CR, Boorman GA, Sills RC. (2000). Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol Pathol 28:529–534.
   PubMed Web of Science ®Google Scholar
• Irons RD. (1990). Studies on the mechanism of 1,3-butadiene-induced leukemogenesis: The potential role of endogenous murine leukemia virus. Environ Health Perspect 86:49–55.
   PubMed Web of Science ®Google Scholar
• Kim Y, Hong H-L Lachat, Y, Clayuton NP, Devereux TR, Melnick RL, Hegi M, Sills RC. (2005). Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice. Toxicol Pathol 33:307–312.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Albertini RJ, Sweeney LM, Gargas ML. (2010). 1,3-Butadiene: I. Review of metabolism and implications to human health risk assessment. Crit Rev Toxicol 40(Suppl 1): this issue.
   Google Scholar
• Kligerman AD, Doerr CL, Tennant AH. (1999). Cell cycle specificity of cytogenetic damage induced by 3,4-epoxy-1-butene. Mutat Res 444:151–158.
   PubMed Web of Science ®Google Scholar
• Koc H, Tretyakova NY, Walker VE, Henderson RF, Swenberg JA. (1999). Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Chem Res Toxicol 12:566–574.
   PubMed Web of Science ®Google Scholar
• Laib RJ, Tucholski M, Filser JG, Csanady GA. (1992). Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats. Arch Toxicol 66:310–314.
   PubMed Web of Science ®Google Scholar
• Larson RA, Le Beau MM. (2005). Therapy-related myeloid leukaemia: A model for leukemogenesis in humans. Chem Biol Interact 153–154:187–195.
   PubMed Web of Science ®Google Scholar
• Leavens TL, Moss OR, Turner MJ, Janszen DB, Bond JA. (1996). Metabolic interactions of 1,3-butadiene and styrene in male B6C3F1 mice. Toxicol Appl Pharmacol 141:628–636.
   PubMed Web of Science ®Google Scholar
• Leavens TL, Farris GM, James RA, Shah R, Wong VA, Marshall MW, Bond JA. (1997). Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene. Environ Mol Mutagen 29:335–345.
   PubMed Web of Science ®Google Scholar
• Levine EG, Bloomfield CD. (1992). Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47–84.
   PubMed Web of Science ®Google Scholar
• Liou SH, Lung JC, Chen YH, Yang T, Hsieh LL, Chen CJ, Wu TN. (1999). Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 59:1481–1484.
   PubMed Web of Science ®Google Scholar
• Loeber R, Rajesh M, Fang Q, Pegg AE, Tretyakova N. (2006). Cross-linking of the human DNA repair protein O6-alkylguanine DNA alkyltransferase to DNA in the presence of 1,2,3,4-diepoxybutane. Chem Res Toxicol 19:645–54.
   PubMed Web of Science ®Google Scholar
• Lovreglio P, Bukvic N, Fustinoni S, Ballini A, Drago I, Foa V, Guanti G, Soleo L. (2006). Lack of genotoxic effect in workers exposed to very low doses of 1,3-butadiene. Arch Toxicol 80:378–381.
   PubMed Web of Science ®Google Scholar
• Macaluso M, Larson R, Lynch J, Lipton S, Delzell E. (2004). Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. J Occup Environ Hyg 1:371–390.
   PubMed Web of Science ®Google Scholar
• Male R, Lillehaug J. R, Djurhuus R, Pryme I.F. (1985). In vitro transformation and tumor promotion studies of styrene and styrene oxide. Carcinogenesis 6:1367–1370.
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653.
   PubMed Web of Science ®Google Scholar
• Meng Q, Henderson R. F, Chen T, Heflich RH, Walker DM, Bauer MJ, Reilly AA, Walker VE. (1999). Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat Res 429:107–125.
   PubMed Web of Science ®Google Scholar
• Meng Q, Henderson RF, Long L, Blair L, Walker DM, Upton PB, Swenberg JA, Walker VE. (2001). Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene. Chem Biol Interact 135–136:343–361.
   PubMed Web of Science ®Google Scholar
• Meng Q, Walker DM, McDonald JD, Henderson RF, Carter MM, Cook DL, McCash CL, Torres SM, Bauer MJ, Sellkop SK, Georgieva NI, Upton PB, Swenberg JA, Walker V. (2007). Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene. Chem Biol Interact 166:121–131.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Heerema NA, Bloomfield C.D. (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Vainio H, Aoyama T. (1993). Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism. IARC Sci Publ 127:101–108.
   Google Scholar
• National Toxicology Program (NTP). (1984). National Toxicology Program Toxicology and carcinogenesis studies of 1,3-butadiene in B6C3F1 mice (inhalation studies). NTP Technical Reports 288.
   Google Scholar
• National Toxicology Program (NTP). (1993). National Toxicology Program Toxicology and carcinogenesis studies of 1,3-butadiene in B6C3F1 mice (inhalation studies). NTP Technical Reports 434.
   Google Scholar
• Okazaki IM, Kotani A, Honjo T. (2007). Role of AID in tumorigenesis. Adv Immunol 94:245–273.
   PubMedGoogle Scholar
• Osterman-Golkar S, Kautiainen A, Bergmark E, Hakansson K, Maki-Paakkanen J. (1991). Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure. Chem Biol Interact 80:291–302.
   PubMed Web of Science ®Google Scholar
• Osterman-Golkar S, Bond JA, Ward JB Jr, Legator MS. (1993). Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene. IARC Sci Publ 127:127–134.
   Google Scholar
• Osterman-Golkar SM, Moss O, James A, Bryant MS, Turner M, Bond JA. (1998) Epoxybutene-hemoglobin adducts in rats and mice: Dose response for formation and persistence during and following long-term low-level exposure to butadiene. Toxicol Appl Pharmacol 150:166–173.
   PubMed Web of Science ®Google Scholar
• Ottmann OG, Wassmann B. (2005). Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology American Society of Hematology Education Program, 118–122.
   PubMedGoogle Scholar
• Owen PE, Glaister JR, Gaunt IF, Pullinger DH. (1987). Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J 48:407–413.
   PubMed Web of Science ®Google Scholar
• Pacchierotti F, Adler ID, Anderson D, Brinkworth M, Demopoulos NA, Lahdetie J, Osterman-Golkar S, Peltonen K, Russo A, Tates A, Waters R. (1998a). Genetic effects of 1,3-butadiene and associated risk for heritable damage. Mutat Res 397:93–115.
   PubMed Web of Science ®Google Scholar
• Pacchierotti F, Tiveron C, Ranaldi R, Bassani B, Cordelli E, Leter G, Spano M. (1998b). Reproductive toxicity of 1,3-butadiene in the mouse: Cytogenetic analysis of chromosome aberrations in first-cleavage embryos and flow cytometric evaluation of spermatogonial cell killing. Mutat Res 397:55–66.
   PubMed Web of Science ®Google Scholar
• Preston RJ. (1999). Chromosomal changes. IARC Sci Publ 146:395–408.
   Google Scholar
• Preston RJ. (2007). Cancer risk for 1,3-butadiene: Data integration opportunities. Chem Biol Interact 166:150–155.
   PubMed Web of Science ®Google Scholar
• Preston RJ, Fennell TR, Leber AP, Sielken RL, Swenberg JA. (1995). Reconsideration of the genetic risk assessment for ethylene oxide. Environ Mol Mutagen 26:189–202.
   PubMed Web of Science ®Google Scholar
• Pyatt DW, Gruntmeir J, Stillman WS, Irons RD. (1998). Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4+ T lymphocytes. Toxicology 128:83–90.
   PubMed Web of Science ®Google Scholar
• Pyatt DW, Yang Y, Le A, Stillman WS, Irons RD. (2000). Dithiocarbamates inhibit hematopoiesis via a copper-dependent mechanism. Biochem Biophys Res Commun 274:513–518.
   PubMed Web of Science ®Google Scholar
• Recio L, Saranko CJ, Steen A-M. (2000). 1,3-Butadiene: Cancer mutations and adducts. Part II. Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Res Rep Health Effects Inst (92):49–87.
   Google Scholar
• Recio L, Steen AM, Pluta LJ, Meyer KG, Saranko CJ. (2001). Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem Biol Interact 135–136:325–341.
   PubMed Web of Science ®Google Scholar
• Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D, Sram R.J. (2005). Chromosome aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113:517–520.
   PubMed Web of Science ®Google Scholar
• Rowley JD. (1998). The critical role of chromosome translocations in human leukemias. Ann Rev Genet 32:495–519.
   PubMed Web of Science ®Google Scholar
• Schreiner E, Freundt KJ. (1986). Inhibition of hepatic epoxide hydrolase and glutathione S-transferase in rats by bis(dimethyldithiocarbamato) zinc (ziram). Bull Environ Contam. Toxicol 37:53–54.
   PubMed Web of Science ®Google Scholar
• Shukla Y, Baqar SM, Mehrotra NK. (1996). Carcinogenic and co-carcinogenic studies of thiram on mouse skin. Food Chem Toxicol 34:283–289.
   PubMed Web of Science ®Google Scholar
• Sielken RL Jr, Valdez-Flores C, Gargas ML, Kirman CR, Teta MJ, Delzell E. (2007). Cancer risk assessment for 1,3-butadiene: Dose-response modeling from an epidemiological perspective. Chem Biol Interact 166:140–149.
   PubMed Web of Science ®Google Scholar
• Sills RC, Hong HL, Melnick RL, Boorman GA, Devereux TR. (1999). High frequency of codon 61 K-ras A→T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis 20:657–662.
   PubMed Web of Science ®Google Scholar
• Sills RC, Hong HL, Boorman GA, Devereux TR, Melnick RL. (2001). Point mutations of K-ras and H-ras genes in forestomach neoplasms from control B6C3F1 mice and following exposure to 1,3-butadiene, isoprene or chloroprene for up to 2-years. Chem Biol Interact 135–136:373–386.
   PubMed Web of Science ®Google Scholar
• Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. (2004a). Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 50:197–222.
   PubMed Web of Science ®Google Scholar
• Smith MT, Skibola CF, Allan JM, Morgan GJ. (2004b) Causal models of leukaemia and lymphoma. In: Buffler P, Rice J, Baan R, Bird M, Boffetta P, eds. Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology. Lyon: IARC. IARC Scientific Publications No. 157.
   Google Scholar
• Swenberg JA, Christova-Gueorguieva NI, Upton PB, Ranasinghe A, Scheller N, Wu KY, Yen TY, Hayes R. (2000). 1,3-Butadiene: Cancer, mutations, adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism. Res Rep Health Effects Inst (92):191–210.
   Google Scholar
• Swenberg JA, Boysen G, Georgieva N, Bird MG, Lewis RJ. (2007). Future directions in butadiene risk assessment and the role of cross-species internal dosimetry. Chem Biol Interact 166:78–83.
   PubMed Web of Science ®Google Scholar
• Ten Berg. (1999). Kaplan-Meier tumor probability as a starting point for dose-response modeling provides accurate lifetime risk estimates from rodent carcinogenicity studies. Ann N Y Acad Sci 895:112–24.
   PubMed Web of Science ®Google Scholar
• Thompson RW, Valentine HL, Valentine WM. (2002). In vivo and in vitro hepatotoxicity and glutathione interactions of N-methyldithiocarbamate and N,N-dimethyldithiocarbamate in the rat. Toxicol Sci 70:269–280.
   PubMed Web of Science ®Google Scholar
• Ton T-V Hong, H-H, Devereux TR, Melnick RL, Sills RR, Kim Y. (2007). Evaluation of genetic alterations in cancer-related genes in lung and brain tumors from B6C3F1 mice exposed to 1,3-butadiene or chloroprene. Chem Biol Interact 166:112–120.
   PubMed Web of Science ®Google Scholar
• Trenga CA, Kunkel DD, Eaton DL, Costa LG. (1991). Effect of styrene oxide on rat brain glutathione. Neurotoxicology 12:165–178.
   PubMed Web of Science ®Google Scholar
• Tsai SP, Ahmed FS, Ransdell JD, Wendt JK, Donnelly RP. (2005). A hematology surveillance study of petrochemical workers exposed to 1,3-butadiene. J Occup Environ Hyg 2:508–515.
   PubMed Web of Science ®Google Scholar
• Turner M, Mantick NA, Carlson GP. (2005). Comparison of the depletion of glutathione in mouse liver and lung following administration of styrene and its metabolites styrene oxide and 4-vinylphenol. Toxicology 206:383–388.
   PubMed Web of Science ®Google Scholar
• US Environmental Protection Agency (US EPA). (1997). Chemical and Radiation Leukemogenesis in Humans and Rodents and the Value of Rodent Models for Assessing Risks of Lymphohematopoietic Cancers. EPA/600/R-97/090. Washington, DC: US EPA.
   Google Scholar
• US Environmental Protection Agency (UEPA). (2002). Environmental Protection Agency. Health Assessment of 1,3-Butadiene. EPA/600/P-98/001F. Washington, DC: US EPA.
   Google Scholar
• US Environmental Protection Agency (US EPA). (2005). Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001B. Washington, DC: US EPA.
   Google Scholar
• Vacek PM, Boysen G, Georgieva N, Swenberg JA, Albertini RJ. (2009). Hemoglobin adducts in 1,3-butadiene exposed Czech workers: Female-male comparisons. Manuscript in preparation.
   Google Scholar
• Walker VE, Meng Q. (2000). 1,3-Butadiene: Cancer mutations and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites. Res Rep Health Effects Inst (92):89–139.
   Google Scholar
• Wang Q, Wang A-h Tan, H-s, Feng N-n Ye, Y-j, Feng X-q Liu, G, Zheng Y-x Xia, Z-l. (2010). Genetic polymorphisms of DNA repair genes and chromosome damage in workers exposed to 1,3-butadiene. Carcinogenesis 31:858–863.
   PubMed Web of Science ®Google Scholar
• Wiseman RW, Cochran C, Dietrich W, Lander ES, Soderkvist P. (1994). Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci U S A 91:3759–3763.
   PubMed Web of Science ®Google Scholar
• Yunis JJ, Boot AJ, Mayer MG, Bos JL. (1989). Mechanisms of ras mutation in myelodysplasticsyndrome. Oncogene 4:609–614.
   PubMed Web of Science ®Google Scholar
• Zenzen V, Fauth E, Zankl H, Janzowski C, Eisenbrand G. (2001). Mutagenic and cytotoxic effectiveness of zinc dimethyl and zinc diisononyldithiocarbamate in human lymphocyte cultures. Mutat Re. 497:89–99.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hayes RB, Guo W, McHale CM, Yin S, Wiencke JK, Patrick OJ, Rothman N, Li GL, Smith MT. (2004). Lack of increased genetic damage in 1,3-butadiene-exposed Chinese workers studied in relation to EPHX1 and GST genotypes. Mutat Res 558:63–74.
   PubMed Web of Science ®Google Scholar
• Zhang XX, Chakrabarti S, Malick AM, Richer CL. (1993). Effects of different styrene metabolites on cytotoxicity, sister-chromatid exchanges and cell-cycle kinetics in human whole blood lymphocytes in vitro. Mutat Res 302:213–218.
   PubMedGoogle Scholar
• Zhuang SM, Eklund LK, Cochran C, Rao GN, Wiseman RW, Soderkvist P. (1996). Allelotype analysis of 2′,3′-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Cancer Res 56:3338–3343.
   PubMed Web of Science ®Google Scholar
• Zhuang SM, Cochran C, Goodrow T, Wiseman RW, Soderkvist P. (1997). Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2′,3′-dideoxycytidine-induced lymphomas. Cancer Res 57:2710–2714.
   PubMed Web of Science ®Google Scholar
• Zhuang SM, Schippert A, Haugen-Strano A, Wiseman RW, Soderkvist P. (1998). Inactivations of p16INK4a-alpha p16INK4a-beta and p15INK4b genes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene 16:803–808.
   PubMed Web of Science ®Google Scholar
• Zhuang S, Soderkvist P. (2000). Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Mutat Res 452:19–26.
   PubMed Web of Science ®Google Scholar
• Zhuang SM, Wiseman RW, Soderkvist P. (2002). Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice. Oncogene 21:5643–5648.
   PubMed Web of Science ®Google Scholar